Safety of perioperative aspirin therapy in pancreatic operations

Surgery (United States)

Volumn 155, Issue 1, 2014, Pages 39-46

  Wolf, Andrea M ^a   Pucci, Michael J ^b   Gabale, Salil D ^b   McIntyre, Caitlin A ^b   Irizarry, Andrea M ^b   Kennedy, Eugene P ^b   Rosato, Ernest L ^b   Lavu, Harish ^b   Winter, Jordan M ^b   Yeo, Charles J ^b  

^a SPECTRUM HEALTH   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT;

ADULT; AGED; ANTICOAGULANT THERAPY; BLOOD TRANSFUSION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLOSTRIDIUM DIFFICILE INFECTION; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG SAFETY; ELECTIVE SURGERY; EMBOLISM; ERYTHROCYTE CONCENTRATE; ERYTHROCYTE TRANSFUSION; FEMALE; GASTRIC DYSMOTILITY; HEART ARRHYTHMIA; HEART ATRIUM ARRHYTHMIA; HEART BLOCK; HEART DISEASE; HEART INFARCTION; HEART VENTRICLE ARRHYTHMIA; HOSPITAL READMISSION; HUMAN; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; OPERATIVE BLOOD LOSS; PANCREAS FISTULA; PANCREAS RESECTION; PANCREAS SURGERY; PANCREATICODUODENECTOMY; PERIOPERATIVE PERIOD; POSTOPERATIVE CARE; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIMARY PREVENTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SECONDARY PREVENTION; SEPSIS; STOMACH EMPTYING; SUDDEN CARDIAC DEATH; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL PATIENT; TRANSIENT ISCHEMIC ATTACK; URINARY TRACT INFECTION; ADOLESCENT; ARTICLE; MIDDLE AGED; STATISTICS; THROMBOSIS; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ASPIRIN; BLOOD LOSS, SURGICAL; FEMALE; HUMANS; LENGTH OF STAY; MALE; MIDDLE AGED; PANCREATECTOMY; PERIOPERATIVE PERIOD; PLATELET AGGREGATION INHIBITORS; RETROSPECTIVE STUDIES; THROMBOSIS; YOUNG ADULT;

EID: 84899487889     PISSN: 00396060     EISSN: 15327361     Source Type: Journal    
DOI: 10.1016/j.surg.2013.05.031     Document Type: Conference Paper

References (24)

1. Wolff T, Miller T, Ko S. Aspirin for the prevention of cardiovascular disease: U.S. Preventative Services Task Force recommendation statement. Ann Intern Med 2009; 150: 396-404.
2. Pignone M, Alberts MJ, Colwell JA, et al. Aspirin for primary prevention of cardiovascular events in people with diabetes: a position statement of the American Diabetes Association, a Scientific Statement of the American Heart Association, and an Expert Consensus Document of the American College of Cardiology Foundation. Circulation 2010; 121: 2694-701.
3. Devereaux PJ, Goldman L, Cook DJ, Gilbert K, Leslie K, Guyatt GH. Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk. Can Med Assoc J 2005; 173: 627-34.
4. Tohgi H, Konno S, Tamura K, Kimura B, Kawano K. Effects of low-to-high doses of aspirin on platelet agreeability and metabolites of thromboxane A2 and prostacyclin. Stroke 1992; 23: 1400-3.
5. Oscarsson A, Gupta A, Fredrikson M, Jarhult J, Nystrom M, Pettersson E, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 2010; 104: 305-12.
6. Mitchell EA, Liem TK. Hemostasis and Thrombosis. In: Moore WS, editor. Vascular and endovascular surgery: A comprehensive review. 7th ed. Philadelphia: Elsevier; 2005. p. 71-2.
7. Scott-Conner CEH, Spence R, Shander A, Singleton C, Bennett H, Rock WA Jr. Hemostasis, thrombosis, hematopoiesis, and blood transfusion. In: O'Leary JP, Capote LR, editors. The physiologic basis of surgery. Baltimore: Lippincott, Williams and Wilkins; 2002. p. 535.
8. Lange RA, Hills LD. Antiplatelet therapy for ischemic heart disease. N Engl J Med 2004; 350: 277-80.
9. Beving H, Zhao C, Albage A, Ivert T. Abnormally high platelet activity after discontinuation of acetylsalicylic acid treatment. Blood Coag Fibrinolysis 1996; 7: 5-99.
10. Harrington RA, Becker RC, Ezekowitz M, Meade TW, O'Connor CM, Vorchheimer DA, et al. Antithrombotic therapy for coronary artery disease: The seventh ACCP conference on antithrombotic and thrombolytic therapy. Chest 2004;126(suppl 3): 513S-48S. (Pubitemid 39302604)
11. Chassot PG, Delabays A, Spahn DR. Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction. Br J Anaesth 2007; 99: 316-28.
12. Biondi-Zoccai GGL, Lotrionte M, Agostoni P, Abbate A, Fusaro M, Burzotta F, et al. A systematic review and metanalysis on the hazards of discontinuing or not adhering to aspirin among 50, 279 patients at risk for coronary artery disease. Eur Heart J 2006; 27: 2667-74.
13. Gerstein NS, Schulman PM, Gerstein WH, Petersen TR, Tawil I. Should more patients continue aspirin therapy perioperatively? Clinical impact of aspirin withdrawal syndrome. Ann Surg 2012; 255: 811-9.
14. Kennedy EP, Rosato EL, Sauter PK, Rosenberg LM, Doria C, Marino IR, et al. Initiation of a critical pathway for pancreaticoduodenectomy at an academic institution - the first step in multi-disciplinary team building. J Am Coll Surg 2007; 204: 917-24.
15. Kennedy EP, Grenda TR, Sauter PK, Rosato EL, Chojnacki KA, Rosato FE Jr, et al. Implementation of a critical pathway for distal pancreatectomy at an academic institution. J Gastrointest Surg 2009; 13: 938-44.
16. Assifi MM, Lindenmeyer J, Leiby BE, Grunwald Z, Rosato EL, Kennedy EP, et al. Surgical Apgar score predicts perioperative morbidity in patients undergoing pancreaticoduodenectomy at a high-volume center. J Gastrointest Surg 2012; 16: 275-81.
17. Lavu H, Kennedy EP, Mazo R, Stewart RJ, Greenleaf C, Grenda DR, et al. Preoperative mechanical bowel preparation does not offer a benefit for patients who undergo pancreaticoduodenectomy. Surgery 2010; 148: 278-84.
18. Berger AC, Howard TJ, Kennedy EP, Sauter PK, Bower-Cherry M, Dutkevitch S, et al. Does type of pancreaticojejunostomy after pancreaticoduodenectomy decrease rate of pancreatic fistula? A randomized, prospective, dualinstitution trial. J Am Coll Surg 2009; 208: 738-49.
19. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo CJ, Izbicki J, et al. International Study Group on Pancreatic Fistula Definition. Postoperative pancreatic fistula: an international study group (ISGPF) definition. Surgery 2005; 138: 8-13.
20. Wente MN, Veit JA, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, et al. Postoperative hemorrhage following pancreatic resection - An International Study Group of Pancreatic Surgery (ISGPS) definition. Surgery 2007; 142: 20-5.
21. Wente MN, Bassi C, Dervenis C, Fingerhut A, Gouma DJ, Izbicki JR, et al. Delayed gastric emptying (DGE) after pancreatic surgery: a suggested definition by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2007; 142: 761-8.
22. O'Riordan JM, Margey RJ, Blake G, O'Connell R. Antiplatelet agents in the perioperative period. Arch Surg 2009; 144: 69-76.
23. Cao L, Young N, Liu H, Silvestry S, Sun W, Zhao N, et al. Preoperative aspirin use and outcomes in cardiac surgery patients. Ann Surg 2012; 255: 399-404.
24. Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention-cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation-review and meta-analysis. J Intern Med 2005; 257: 399-414.